Cargando…

The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals

BACKGROUND: Multidrug resistance (MDR) of cancers can be circumvented by inducing programmed cell death, which is known as apoptosis. Mitochondria play a crucial role in apoptosis. Mitochondria-specific therapy would provide an efficient strategy for treating resistant cancers. DESIGN AND METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Men, Ying, Wang, Xiao-Xing, Li, Ruo-Jing, Zhang, Yan, Tian, Wei, Yao, Hong-Juan, Ju, Rui-Jun, Ying, Xue, Zhou, Jia, Li, Nan, Zhang, Liang, Yu, Yang, Lu, Wan-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235031/ https://www.ncbi.nlm.nih.gov/pubmed/22163164 http://dx.doi.org/10.2147/IJN.S24847

Ejemplares similares

The use of functional epirubicin liposomes to induce programmed death in refractory breast cancer
por: Liu, Lei, et al.
Publicado: (2017)

Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles
por: Casals, Eudald, et al.
Publicado: (2017)

Nanostructured Dihydroartemisinin Plus Epirubicin Liposomes Enhance Treatment Efficacy of Breast Cancer by Inducing Autophagy and Apoptosis
por: Hu, Ying-Jie, et al.
Publicado: (2018)

Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma
por: Ju, Rui-Jun, et al.
Publicado: (2016)

Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas
por: Kong, Dehua, et al.
Publicado: (2022)

Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer
por: Song, Xiao-li, et al.
Publicado: (2017)

Vitamin C-driven epirubicin loading into liposomes
por: Lipka, Dominik, et al.
Publicado: (2013)

A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment
por: Zhang, Cheng-Xiang, et al.
Publicado: (2015)

RPV‐modified epirubicin and dioscin co‐delivery liposomes suppress non‐small cell lung cancer growth by limiting nutrition supply
por: Kong, Liang, et al.
Publicado: (2020)

The Fate of Sialic Acid and PEG Modified Epirubicin Liposomes in Aged versus Young Cells and Tumor Mice Models
por: Sui, Dezhi, et al.
Publicado: (2022)

Comparable efficacy and less toxicity of pegylated liposomal doxorubicin versus epirubicin for neoadjuvant chemotherapy of breast cancer: a case-control study
por: Dong, Minjun, et al.
Publicado: (2018)

The effect of monosialylganglioside mix modifying the PEGylated liposomal epirubicin on the accelerated blood clearance phenomenon
por: Zhang, Ting, et al.
Publicado: (2017)

Epirubicin
por: Cornish, J., et al.
Publicado: (1988)

Epirubicin-induced Kounis syndrome
por: Liang, Hui-zhu, et al.
Publicado: (2021)

Pegylated Liposomal Doxorubicin Versus Epirubicin as Adjuvant Therapy for Stage I–III Breast Cancer
por: Hu, Wenxian, et al.
Publicado: (2021)

Application of Multifunctional Targeting Epirubicin Liposomes in the Treatment of Non-Small-Cell Lung Cancer [Corrigendum]
Publicado: (2021)

Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: a real-world study
por: Zhang, Jin, et al.
Publicado: (2021)

Ulinastatin Reduces the Resistance of Liver Cancer Cells to Epirubicin by Inhibiting Autophagy
por: Song, Bin, et al.
Publicado: (2015)

Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells
por: Li, Xue-Tao, et al.
Publicado: (2014)

Metformin Alleviates Epirubicin-Induced Endothelial Impairment by Restoring Mitochondrial Homeostasis
por: Sun, Qi, et al.
Publicado: (2022)

Effect of Epirubicin Plus Paclitaxel vs Epirubicin and Cyclophosphamide Followed by Paclitaxel on Disease-Free Survival Among Patients With Operable ERBB2-Negative and Lymph Node–Positive Breast Cancer: A Randomized Clinical Trial
por: Yuan, Peng, et al.
Publicado: (2023)

A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy
por: Liu, Ching-Wen, et al.
Publicado: (2016)

Accelerated drug release and clearance of PEGylated epirubicin liposomes following repeated injections: a new challenge for sequential low-dose chemotherapy
por: Yang, Qiang, et al.
Publicado: (2013)

Melatonin protects against Epirubicin-induced ovarian damage
por: WANG, Naiqiang, et al.
Publicado: (2019)

Study on the infusion-site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant
por: Yamasaki, Miho, et al.
Publicado: (2019)

Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2–3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells
por: Juang, Vivian, et al.
Publicado: (2016)

Study of epirubicin sustained–release chemoablation in tumor suppression and tumor microenvironment remodeling
por: Meng, Liangliang, et al.
Publicado: (2022)

Efficacy and Safety of Epirubicin Combined with Temozolomide for Treatment of Advanced Leiomyosarcoma
por: Tan, Huijing, et al.
Publicado: (2021)

HAase-sensitive dual-targeting irinotecan liposomes enhance the therapeutic efficacy of lung cancer in animals
por: Zhang, Liang, et al.
Publicado: (2018)

Chloroquine increases the anti-cancer activity of epirubicin in A549 lung cancer cells
por: Liang, Ai-Ling, et al.
Publicado: (2020)

Transcatheter embolization of hepatocellular carcinoma with epirubicin-loaded DC beads in Chinese patients
por: Zhou, Guan-Hui, et al.
Publicado: (2019)

Charge Conversion Polymer–Liposome Complexes to Overcome the Limitations of Cationic Liposomes in Mitochondrial-Targeting Drug Delivery
por: Shueng, Pei-Wei, et al.
Publicado: (2022)

Clinical Application of the Heart Rate Deceleration Capacity Test to Predict Epirubicin-induced Cardiotoxicity
por: Feng, Yan-ying, et al.
Publicado: (2015)

Cepharanthine sensitizes human triple negative breast cancer cells to chemotherapeutic agent epirubicin via inducing cofilin oxidation-mediated mitochondrial fission and apoptosis
por: Shen, Li-wen, et al.
Publicado: (2021)

Randomised trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas.
por: Topham, C., et al.
Publicado: (1991)

Dose-dense paclitaxel plus carboplatin vs. epirubicin and cyclophosphamide with paclitaxel as adjuvant chemotherapy for high-risk triple-negative breast cancer
por: Li, Qing, et al.
Publicado: (2020)

Effect of sun ginseng potentiation on epirubicin and paclitaxel-induced apoptosis in human cervical cancer cells
por: Lin, Yingjia, et al.
Publicado: (2014)

The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals
por: Wang, Yahua, et al.
Publicado: (2017)

Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer’s Disease-Related Pathology in APP/PS-1 Mice
por: Kong, Liang, et al.
Publicado: (2020)

Polyphosphazene-Based Nanocarriers for the Release of Camptothecin and Epirubicin
por: Quiñones, Javier Pérez, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0it8vbt6vt2jaq0nt61hsa9l3r